COMMODORE CAPITAL LP
SEC CIK 1831942 · EDGAR
BoughtSold
Most active insiders at VERA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fordyce Marshall | Pres AND CEO, Dir | — | $9.73M |
| 2 | Turner William D. | Chief Regulatory Off | — | $1.45M |
| 3 | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | — | $566.8K |
| 4 | ENRIGHT PATRICK G | Dir | $250.0K | — |
| 5 | Grant Sean | CFO | — | $207.8K |
| 6 | JOHNSON DAVID LEE | COO | — | $108.3K |
| 7 | Carter Jason S | CLO | — | $107.5K |
| 8 | Brenner Robert | Chief Medical Off | — | $90.3K |
| 9 | Skelton Laurence Matthew | Chief Commercial Off | — | $66.4K |
| 10 | Boman Nancy Lee | Chief Regulatory Off | — | — |
COMMODORE CAPITAL LP made no open-market trades at VERA in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-01-12 | 2024-01-10 | VERA | Vera Therapeutics, Inc. | COMMODORE CAPITAL LP | 10% | S - Sale | $18.00 | -1.05M | 4.40M | -19% | -$18.90M |
| I | 2023-08-09 | 2023-08-07 | VTGN | Vistagen Therapeutics, Inc. | COMMODORE CAPITAL LP | 10% | P - Purchase | $23.15 | +775.8K | 1.57M | +97% | +$17.96M |
| I | 2023-06-22 | 2023-06-20 | VERA | Vera Therapeutics, Inc. | COMMODORE CAPITAL LP | 10% | P - Purchase | $15.17 | +448.2K | 5.45M | +9% | +$6.80M |
| I | 2023-02-27 | 2023-02-23 | ELVN | Enliven Therapeutics, Inc. | COMMODORE CAPITAL LP | 10% | P - Purchase | $22.07 | +621.75 | 718.7K | +0.1% | +$13.7K |
| I | 2023-02-27 | 2023-02-23 | ELVN | Enliven Therapeutics, Inc. | COMMODORE CAPITAL LP | 10% | J - Other | — | +729.9K | 1.45M | +102% | — |
| MI | 2023-02-23 | 2023-02-21+ | ELVN | Enliven Therapeutics, Inc. | COMMODORE CAPITAL LP | 10% | P - Purchase | $5.15 | +31.8K | 2.87M | +1% | +$163.4K |
Purchase Sale Sale after option exercise All abbreviations